HuGE Literature Finder
Records
1
-
4
Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer. European journal of cancer (Oxford, England : 1990) 2021 Nov . Peralta-Arrieta Irlanda, Trejo-Villegas Octavio A, Armas-López Leonel, Ceja-Rangel Hugo A, Ordóñez-Luna María Del Carmen, Pineda-Villegas Priscila, González-López Marco A, Ortiz-Quintero Blanca, Mendoza-Milla Criselda, Zatarain-Barrón Zyanya L, Arrieta Oscar, Zúñiga Joaquín, Ávila-Moreno Federi |
Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. BioMed research international 2020 2020 2380124. Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa |
Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer. Anticancer research 2018 Jun 38 (6): 3707-3711. Toyokawa Gouji, Takada Kazuki, Tagawa Tetsuzo, Kinoshita Fumihiko, Kozuma Yuka, Matsubara Taichi, Haratake Naoki, Takamori Shinkichi, Akamine Takaki, Hirai Fumihiko, Yamada Yuichi, Hamamoto Ryuji, Oda Yoshinao, Maehara Yoshihi |
Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Jan 5 (1): 10-6. Yoon Kyong-Ah, Gil Hye Jin, Han Jihye, Park Jaehee, Lee Jin S |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: